KRAS and malignant colon neoplasm: Indeed, Grunt and colleagues found co-expression patterns of the stem cell markers CD133 and CD26 on KRAS-mutated HC116 colon cancer cells, showing that the co-expression of these markers enhances long-term growth and increased resistance to anticancer agents (42).